Lastly, insulin signaling within the central nervous system has neuroprotective roles, and disruption of these insulin‐signaling pathways due to insulin resistance may negatively affect neuroplasticity, particularly within hippocampal and prefrontal cortical regions, thereby exacerbating cognitive decline and heightening susceptibility to depression. Here, INS is linked to depressive symptom measurement.